When treatment is delayed for hepatitis C, the initial cost savings are eclipsed by the later costs of more complex treatment.
The business practices of medicine are keeping people with hepatitis C sick longer in the interest of saving money in the short term, but the cost of treating them when they get worse costs a lot more.
Treating and curing hepatitis C patients would likely cost a lot of money up front, but researchers say the nearly $1 trillion saved over the next two decades and attention paid to other diseases could result in lives saved and a healthier populace, researchers at the University of Southern California found in a series of studies published in the American Journal of Managed Care.
Hepatitis C is caused by a virus that attacks the liver, with roughly half the 3.5 million Americans who have it unaware they are infected, according to the U.S. Centers for Disease Control and Prevention.
A three-month course of treatment for hepatitis C runs between $54,600 and $94,500, according to the Boston Globe, which reports many insurance companies wait as long as possible to approve paying for the treatment.
Read Full Article: Study: Cheaper to cure hepatitis C sooner than later – UPI.com
|Read Full Article: Study: Cheaper to cure hepatitis C sooner than later – UPI.com|